Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-22-016598
Filing Date
2022-08-23
Accepted
2022-08-23 16:34:06
Documents
1
Period of Report
2022-08-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3853
  Complete submission text file 0001567619-22-016598.txt   5438
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Issuer) CIK: 0001533743 (see all company filings)

EIN.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PROCESSA PHARMACEUTICALS, INC. 7300 COCA COLA DRIVE, SUITE 106 HANOVER MD 21076
Business Address
Floyd Robert Michael (Reporting) CIK: 0001828217 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39531 | Film No.: 221187930